Effect of Cold Hemodialysis on Hemoglobin and Hematocrit in Hemodialysis Patients: A Crossover Clinical Trial Study

AUTHORS

Fatemeh Moradi ORCID 1 , Mohammad Reza Din Mohammadi 1 , Vahideh Karimi 1 , Ramazan Fallah 2 , Ali Imani ORCID 1 , *

1 Faculty of Nursing and Midwifery, Zanjan University of Medical Sciences, Zanjan, Iran

2 Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

How to Cite: Moradi F, Din Mohammadi M R, Karimi V, Fallah R, Imani A. Effect of Cold Hemodialysis on Hemoglobin and Hematocrit in Hemodialysis Patients: A Crossover Clinical Trial Study, Med Surg Nurs J. Online ahead of Print ; 8(2):e95478. doi: 10.5812/msnj.95478.

ARTICLE INFORMATION

Medical - Surgical Nursing Journal: 8 (2); e95478
Published Online: June 24, 2019
Article Type: Research Article
Received: June 18, 2019
Accepted: June 18, 2019
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: One of the common complications of renal failure in hemodialysis patients which has a negative impact on quality of life is anemia. Various studies showed that cold hemodialysis could improve hemodialysis complications such as pruritus, sleep disorders and fatigue.

Objectives: The aim of this study was determine the effect of cold hemodialysis on hemoglobin and hematocrit level in hemodialysis patients.

Methods: This research was a double-blind crossover randomized clinical trial study. 42 hemodialysis patients were divided into two groups (22 in the first group and 20 in the second group). The first group received standard hemodialysis temperature (fluid 37°C) in the first four weeks and simultaneously the second group received cold hemodialysis (fluid 35°C), in the second phase, four weeks later, the type of hemodialysis was changed in two groups. During the study, hemoglobin and hematocrit levels of patients were measured several times.

Results: The results showed that in the first and second groups respectively, 55 and 32 percent of patients were in the age range of 50 - 65 years. Hemoglobin and hematocrit levels before the study in the two groups was not statistically significant (P: 0.19). But after the first four weeks, the mean of hemoglobin in the cold and standard hemodialysis were 13.85 vs. 11.9 and hematocrit 43.83 vs. 38.02, respectively and after the second four weeks the average hemoglobin in the cold and standards hemodialysis were 13.57 vs. 11.47, respectively and hematocrit 43.29 vs. 37.18. Crossover outcomes of the groups’ analysis showed that cold hemodialysis significantly increased hemoglobin and hematocrit levels in hemodialysis patients (P < 0.001).

Conclusions: The mean of hemoglobin and hematocrit was different between two groups and significantly higher in cold hemodialysis.

Keywords

Anemia Cold Hemodialysis End Stage Renal Disease Hemoglobin

Copyright © 2019, Medical - Surgical Nursing Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

Hemodialysis is one of the replacement therapies in acute and chronic kidney failure to maintain stability in the body's internal environment (1-4). However, renal failure may cause undesirable effects such as decrease of hemoglobin and hematocrit (5), sleep disorders (4), loss of blood pressure (6, 7), quality of life disorder, and pruritus (8-11). Decrease of hemoglobin and hematocrit is one of the common chronic problems in kidney failure, which can even further aggravate the other complications (12). This is found in 60% - 80% patients with advanced kidney failure (12, 13) its intensity increases with decreasing kidney function (13, 14).

Decrease in hemoglobin and hematocrit levels in these patients causes dizziness, light headache, tinnitus, palpitation, dyspnea, intolerance of cold, weakness, fatigue, and intolerance of activity, the lack of treatment associated with physiological disorders, mainly cardiovascular disease (15), left ventricular hypertrophy, heart failure, and death (13, 14, 16).

Anemia in these patients reduces their quality of life (12, 17) and is directly associated with the degree of physical activity, sleep and general health (12). Considering that anemia causes many problems for hemodialysis patients, this has been the focus of researchers, among these studies, the effect of cold hemodialysis in hemodialysis patients can be noted in Iran.

The use of cold hemodialysis as an effort to control hypotension during the hemodialysis began in 1980 (18, 19). After that, researchers found that cold hemodialysis not only reduces the periods of hypotension during hemodialysis but also has other useful effects on overall health and quality of life (20). The study of Imani and colleagues in 2011 was done in Semnan with the aim of investigating the influence of cold hemodialysis on the pruritus of hemodialysis patients. In this study, 35 hemodialysis patients were dialyzed for one month with the standard hemodialysis (37°C) and one more month with the same variables with the cold hemodialysis (35°C). The results showed the positive effect of cold hemodialysis on the reduction of the pruritus in these patients (8).

In the retrospective study of the total death and death rate from heart and non-heart disease in the two groups of patients who received cold hemodialysis with lower temperature of 35.5°C and standard hemodialysis with 37°C showed that cold hemodialysis significantly reduces the total mortality and mortality caused by heart disease but has no effect on non - heart disease death (21).

Another clinical trial aimed at investigating the influence of cold hemodialysis on the microscopic structure of the brain, in which 38 patients in the two standard and cold hemodialysis groups were studied for one year, brain scans revealed that cold hemodialysis significantly reduces brain damage, which is due to more hemodynamic stability in the cold method (22). Other similar studies indicate that cold hemodialysis improves sleep disorders (23), itching (8), and hemodialysis efficiency (24). In fact, cold- dialysis seems to be associated with a long-term improvement in the level of hemoglobin in patients because of less hypotension, better tolerance of dialysis which will improve the adequacy of dialysis and urea clearance. Some studies showed that hemodiafiltration is associated with better tolerance to ultrafiltration and less hypotension than hemodialysis due to lower temperature of dialysis solution (25).

Several articles have demonstrated that cold hemodialysis is a harmless procedure, we can refer to the review of Sakkas et al. in 2017; showing that cold hemodialysis did not have any hazardous effects (26). It seems, though that the harmor effectiveness of the cold hemodialysis on the hemoglobin and hematocrit changes have not been investigated and according to the adverse effects of anemia, we need to know how cooling of hemodialysis fluid affects the hemoglobin and hematocrit in hemodialysis patients.

2. Objectives

The aim of this study was to investigate the effect of cold hemodialysis on the rate of hemoglobin and hematocrit in hemodialysis patients.

3. Methods

This research was a double-blind crossover randomized clinical trial study, which was performed in Valliasr Hospital in the city of Zanjan in 2016. Patients were unaware of what type of hemodialysis they received, and the person who collected the information was unaware of the purpose of the study. When the patients came for obtaining the consent form, they were notified about cold hemodialysis; but they did not know when the cold hemodialysis would be received.

The number of 42 hemodialysis patients was selected based on the results of previous studies (4, 8). The inclusion criteria included: type of vascular access being fistula; previous hemodialysis for at least six months, three sessions of hemodialysis in a week four hours in every session The exclusion criteria included: bleeding during hemodialysis, patients receiving blood, change in erythropoietin dose, discontinuation of hemodialysis (kidney transplant, vascular problem), changes of hemodialysis dose.

Before the intervention began, the study was approved by the Ethics Committee of Zanjan University of Medical Sciences (ZUMS.REC. 1394.75) and written consent was obtained from the patients. The sample was randomly divided into two groups of 20 and 22 numbers. The first group, which included 20 patients, received standard hemodialysis for the first four weeks (37°C) and cold hemodialysis (35°C) for the second four weeks. The second group, which included 22 patients, received cold hemodialysis for the first four weeks (35°C) and standard hemodialysis (37°C) for the second four weeks. The sequences of intervention for each group were randomly selected.

During the study, patients were dialyzed with available and fixed dialysis machine for three sessions, four hours each week. Type of dialysis machine, the pump type and UF were the same throughout different sessions in each patient. Before and after the intervention, the temperature of the dialysis fluid was regulated by the temperature adjustment profile on the dialysis machine.

The data collection tool included; demographic information form (age, gender, employment, marital status, education, duration of hemodialysis, cause of hemodialysis) and the amount of hemoglobin and hematocrit at three stages, i.e. before the beginning of the study, and the completion of the first four weeks and the end of the second four weeks. Prior to the separation of the patient from the machine, 1 ml of blood was derived from hemodialysis line and sent to the laboratory of Valliasr Hospital in a laboratory tube containing anti-coagulants to measure the level of hemoglobin and the hematocrit. In this laboratory, all blood analyses were carried out with a single cell counter device.

The obtained data was analyzed in SPSS 22 with descriptive statistics, Man Whitney and Freedman. The significance level of P < 0.05 was considered.

4. Results

Of the 42 patients divided into two groups, there were 11 men (55%) and 9 women (45%) in the first group and 8 men (36.4%) and 14 women (63.6%) in the second group. Demographic data of the samples are summarized in Table 1. The mean and standard deviation of the hemoglobin level in the pre study stage was not statistically significant; but after the first four weeks of the mean and standard deviation of hemoglobin at the cold and standard hemodialysis stage respectively were 13.85 ± 1.81 and 11.09 ± 1.08. After the second four weeks, the mean and standard deviation of hemoglobin at the cold and standard hemodialysis stage respectively were 13.57 ± 1.50 and 11.47 ± 0.87. The cross sectional survey of groups showed that groups were significantly different; data are summarized in Table 2.

Table 1. The Frequency Distribution Demographic Information of the Hemodialysis Patients in the Two Groups of Cold and Standard Hemodialysis
Type of Hemodialysis/VariationFirst GroupSecond Group
FrequencyPercentFrequencyPercent
Age
< 50525627.3
50 - 651155731.8
> 65420940.9
Marriage
Single21014.5
Married16801777.3
Widow210418.2
Education
Uneducated and basic10501463.7
Secondary education420731.8
Diploma63014.5
Employment
Unemployed or retirement735940.9
Employee1500
Homemaker9451359.1
Others31500
Residence
Urban13651672.7
Rural735627.3
Table 2. Comparison the Mean and Standard of the Hemoglobin Level on the Standard and Cold Hemodialysis in Hemodialysis Patients
Time/GroupHemoglobin Level
NumberMean ± SDP Value
Before0.193a
First group2013.70 ±3.52
Second group2212.57 ±1.82
First 4 week0.001b
Cold2013.85 ±1.31
Standard2212.51 ±2.08
Second 4 week
Standard2012.47 ±1.57
Cold2213.57 ±1.50

aManwhitney test.

bFridman test.

The difference in the mean of the hematocrit and hemoglobin level in the pretest study stage in the two groups was not statistically significant. After the first four weeks, the mean of hematocrit at the cold and standard hemodialysis stage were 43.83 ± 5.33 and 38.02 ± 2.15 respectively, and after the second four weeks, the mean and standard deviation of hematocrit at the cold and standard hemodialysis stage were 42.29 ± 5.53 and 39.18 ± 4.56, respectively. The crossover survey of groups showed that cold dialysis contributes to differences in the two groups; data are summarized in Table 3.

Table 3. Comparison the Mean and Standard of the Hematocrit Level on the Standard and Cold Hemodialysis in Hemodialysis Patients
Time/GroupHematocrit
NumberMean ± SDP Value
Before0.221a
First group2042.24 ± 9.26
Second group2239.27 ± 6.03
First 4 week0.001b
Cold2042.83 ± 4.33
Standard2240.02 ± 7.15
Second 4 week
Standard2039.18 ± 4.56
Cold2242.29 ± 5.56

aMann Whitney test.

bFriedman test.

5. Discussion

The present study aimed to investigate the effect of cold hemodialysis on hemoglobin and hematocrit in hemodialysis patients. According to the results of this study, cold hemodialysis has not only a negative effect on hemoglobin and hematocrit but also contributes to differences in the two groups. As mentioned, the reasons for this research were the lack of an article in this regard, so in this section we have discussed the studies done on the topic of cold hemodialysis.

The study of Imani and colleagues in 2017, which was aimed at the effect of cold hemodialysis on the pruritus between 35 hemodialysis patients in a pre and post group, showed that cold hemodialysis significantly contributed to relief of pruritus and according to patients, they felt better and more comfortable with cold hemodialysis. Most of them tended to be dialyzed again with cold hemodialysis (8).

Another study was carried out by Parker et al. in 2007 in the United States with the aim of reducing the temperature of dialysis to improve sleep and changing night skin temperatures in chronic hemodialysis patients. Sleep criteria were assessed by the polysomnography device and axillary temperature was measured by the Minilogger 2000. During this study, the cold hemodialysis had been able to accelerate the start of the dream, although differences in other sleep factors such as REM and total sleep time were not statistically significant, but they were better than the standard hemodialysis (27). There were limitations in the Parker study which can be referred to as the low number of samples, short duration of follow-up and the sensitivity of polysomnography (23).

However, another clinical trial conducted by Ayub et al. in New Zealand, aimed at the effect of cooling the hemodialysis fluid temperature on the dialysis adequacy. Samples included 10 patients divided into two groups of 5. Patients were dialyzed 6 sessions, three sessions with normal temperature (standard hemodialysis) and three other sessions with cold temperature. This study showed that cold hemodialysis with the stabilization of hemodynamic status helps to increase ultrafiltration during and after hemodialysis. During hemodialysis, cold hemodialysis can be effective in Kt/V (K, dialyzer clearance of urea; t, dialysis time; V, volume of distribution of urea) and URR (urea reduction ratio) in patients with low blood pressure compared to patients with stable blood pressure. In both groups, the majority of patients (80%) reported being more energetic and had an enormous improvement in their overall health, they tended to be dialyzed with cold type (28). In this study, patients were not aware of the type of hemodialysis until they were questioned about the individual's sense of cold hemodialysis.

In another study, the results showed that patients who received cold hemodialysis at 35 ° C were willing to continue this approach in subsequent dialysis sessions, and 76% - 80% of the subjects had a high energy feeling and a significant increase in general health (24).

There is no hypothesis about the mechanism of the effect of cold hemodialysis on the increase in hemoglobin and hematocrit levels, but most of the studies on cold hemodialysis represent an increase in hemodynamic stability during the hemodialysis and prevention of blood pressure decrease (24, 27, 29, 30). Since the hypotensive episodes are one of the most common causes of the unwanted reasons for hemodialysis to be interrupted and these interruptions can reduce the effectiveness and adequacy of hemodialysis, it strengthens the hypothesis that intermittent hemodialysis interruptions may have led to an increase in uremia in these patients and then increase the negative effects of uremia on the blood factors such as Hb and Hct. Cold hemodialysis though, could prevent discontinuing the hemodialysis by the prevention of hypotension. On the other hand, research has shown that this method has had a positive effect on the removal of urea, Kt/v, (24, 28, 31). The cooling of hemodialysis fluid may reduce uremic effects as a destructive factor on red blood cells.

The result of this study showed that cold hemodialysis with a temperature of 35°C does not only have a negative effect on hemoglobin and hematocrit, but also contributes to differences in the two groups

5.1. Conclusions

This study demonstrates the positive effects of cold dialysis on Hb and Hct in hemodialysis patients. Therefore, it is suggested that this method be considered as an alternative treatment method along with drug therapy as a less costly method. Given the fact that the effect of cold dialysis on the anemia of dialysis patients is less studied, it is suggested that further studies in this area be conducted with a longer duration of intervention and follow-up period.

Acknowledgements

Footnotes

References

  • 1.

    da Silva GL, Thome EG. [Complications of the hemodialysis procedure in acute renal failure patients: nursing interventions]. Rev Gaucha Enferm. 2009;30(1):33-9. Portuguese. [PubMed: 19653553].

  • 2.

    Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine. 19 ed. Tehran: Teimorzadeh; 2015.

  • 3.

    Monfared A, Orangpour A, Kahni M. [Massessing dialysis adequacy in hemodialysis patients in health education centers in Rasht]. Med J Gilan. 2008;17(65):44-9. Persian.

  • 4.

    Soleimani M, Asgari M, Imani A, Tammadon M. [The effect of cool temperature dialysate on sleep quality in hemodialysis patients]. J Zanjan Univ Med Sci. 2017;25(111):128-38. Persian.

  • 5.

    Asgari M, Soleimani M. The comprehensive book of intensive nursing in ICU, CCU and dialysis wards. 4 ed. Tehran: Boshra-Tohfe; 2017.

  • 6.

    Rad M, Jaghouri E, Sharifipour F, Rakhshani MH. The effects of cool dialysate on pruritus status during hemodialysis of patients with chronic renal failure: A controlled randomized clinical trial. Iran Red Crescent Med J. 2016;19(1). doi: 10.5812/ircmj.34759.

  • 7.

    Zakeri Moghddam M, Ali Asgharpoor M. critical care nursing in ICU, CCU and dialysis ward. 7 ed. Tehran: Andisheh Rafi; 2015.

  • 8.

    Imani A, Soleimani M, Asgari M, Moradi F, Pourrahimi A, Tammadon M. [The effect of cold hemodialysis fluid on the Uremia pruritus in hemodialysis patients]. J Knowledge Health. 2018;12(4):33-9. Persian.

  • 9.

    Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2006;151(2):492-500. doi: 10.1016/j.ahj.2005.03.055. [PubMed: 16442920].

  • 10.

    Karimi S, Heidary Seraj. M , Afshar R. [Evaluation of uremic pruritus and its associated factors in hemodialysis patients]. Daneshvar Med. 2014;22(113):29-36. Persian.

  • 11.

    Strippoli GF, Manno C, Schena FP, Craig JC. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database Syst Rev. 2003;(1). CD003967. doi: 10.1002/14651858.CD003967. [PubMed: 12535495].

  • 12.

    Virani SA, Khosla A, Levin A. Chronic kidney disease, heart failure and anemia. Can J Cardiol. 2008;24 Suppl B:22B-4B. doi: 10.1016/s0828-282x(08)71026-2. [PubMed: 18629385]. [PubMed Central: PMC2794442].

  • 13.

    Kdoqi. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50(3):471-530. doi: 10.1053/j.ajkd.2007.06.008. [PubMed: 17720528].

  • 14.

    Nissenson A, Fine R. Dialysis therapy. Philadelphia: Hanley & Belfus; 2012.

  • 15.

    Negishi K, Kobayashi M, Ochiai I, Yamazaki Y, Hasegawa H, Yamashita T, et al. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T. Circ J. 2010;74(12):2734-40. doi: 10.1253/circj.CJ-10-0355. [PubMed: 21041973].

  • 16.

    Locatelli F, Pozzoni P, Del Vecchio L. Anemia and heart failure in chronic kidney disease. Semin Nephrol. 2005;25(6):392-6. doi: 10.1016/j.semnephrol.2005.05.008. [PubMed: 16298261].

  • 17.

    Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis. 1999;34(6):1089-95. doi: 10.1016/S0272-6386(99)70015-6. [PubMed: 10585319].

  • 18.

    Maggiore Q, Pizzarelli F, Zoccali C, Sisca S, Nicolo F, Parlongo S. Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc Eur Dial Transplant Assoc. 1981;18:597-602. [PubMed: 7329988].

  • 19.

    Mahida BH, Dumler F, Zasuwa G, Fleig G, Levin NW. Effect of cooled dialysate on serum catecholamines and blood pressure stability. Trans Am Soc Artif Intern Organs. 1983;29:384-9. [PubMed: 6673258].

  • 20.

    Toth-Manikowski SM, Sozio SM. Cooling dialysate during in-center hemodialysis: Beneficial and deleterious effects. World J Nephrol. 2016;5(2):166-71. doi: 10.5527/wjn.v5.i2.166. [PubMed: 26981441]. [PubMed Central: PMC4777788].

  • 21.

    Hsu HJ, Yen CH, Hsu KH, Lee CC, Chang SJ, Wu IW, et al. Association between cold dialysis and cardiovascular survival in hemodialysis patients. Nephrol Dial Transplant. 2012;27(6):2457-64. doi: 10.1093/ndt/gfr615. [PubMed: 22058176].

  • 22.

    Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015;26(4):957-65. doi: 10.1681/ASN.2013101086. [PubMed: 25234925]. [PubMed Central: PMC4378094].

  • 23.

    Parker KP, Bailey JL, Rye DB, Bliwise DL, Van Someren EJ. Lowering dialysate temperature improves sleep and alters nocturnal skin temperature in patients on chronic hemodialysis. J Sleep Res. 2007;16(1):42-50. doi: 10.1111/j.1365-2869.2007.00568.x. [PubMed: 17309762].

  • 24.

    Taher Azar A. Effect of dialysis temperature on hemodynamic stability among hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;4:596-603.

  • 25.

    Daugirdas JT, Blake PG, Ing TS. Handbook of dialysis. Lippincott Williams & Wilkins; 2012.

  • 26.

    Sakkas GK, Krase AA, Giannaki CD, Karatzaferi C. Cold dialysis and its impact on renal patients' health: An evidence-based mini review. World J Nephrol. 2017;6(3):119-22. doi: 10.5527/wjn.v6.i3.119. [PubMed: 28540201]. [PubMed Central: PMC5424433].

  • 27.

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019-32. doi: 10.1056/NEJMoa0907845. [PubMed: 19880844].

  • 28.

    Ayoub A, Finlayson M. Effect of cool temperature dialysate on the quality and patients' perception of haemodialysis. Nephrol Dial Transplant. 2004;19(1):190-4. doi: 10.1093/ndt/gfg512. [PubMed: 14671056].

  • 29.

    Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Liu J, Winkelmayer WC. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010;303(9):857-64. doi: 10.1001/jama.2010.206. [PubMed: 20197532].

  • 30.

    Lilien MR, Duran M, Quak JM, Frankhuisen JJ, Schroder CH. Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis. Pediatr Nephrol. 2000;15(1-2):17-20. doi: 10.1007/s004670000423. [PubMed: 11095004].

  • 31.

    McGann KP, Marion GS, Camp L, Spangler JG. The influence of gender and race on mean body temperature in a population of healthy older adults. Arch Fam Med. 1993;2(12):1265-7. doi: 10.1001/archfami.2.12.1265. [PubMed: 8130908].

  • COMMENTS

    LEAVE A COMMENT HERE: